| |
 Search  Advanced Tutorial Results Saved Refs ( 0) About
Tutorial Introduction This tutorial with help you learn what makes Twease different and how Twease can help you find what you are looking for, fast. Twease is a web-based tool to search Medline® abstracts. Twease indexes each word of Medline® and provides features that can transparently expand your search to help find the information you are looking for. Twease searches are also partially case sensitive. Short terms are case sensitive, while longer terms are not. For instance, TnT is different from TNT (TnT often stands for Troponin T while TNT often stands for trinitrotoluene). For more details on Twease's case sensitivity, see the Case Sensitive Searches tutorial page. Finally, Twease can automatically discover common abbreviations for search phrases (e.g., "protein kinase C" will discover PKC, PK-C, aPKC, etc.) and rewrite queries to use these abbreviations. This feature is available through the Slider (on the top right) and the Advanced pane. To learn more about searching Twease, visit the rest of this tutorial.
 |
|
Twease
helps you find precisely what you're looking for,
quickly. Search
Medline®
abstracts
in new ways and find the information you need. Type your search
phrase here and click "Search" to get started,
or, take a tour of
Twease
with our Tutorial.
|
|
You have no saved references. Click  within Query Results to save references.
Open the Saved Refs pane to view / export your saved references.
|
 |
|
Query Stats
|
|
doclookup-time
|
294
|
|
queue-time
|
0
|
|
exec-time
|
549
|
|
total-exec-time
|
843
|
|
Last Executed Query:
pmid-list:4910210,5837985,4875065,4360125,6232062,13947158,13947159,3013095,14139486,6445411,5116727,14739488,7704790,2561752,3686841,15718329,4409747,4361017
|
|
Query Results 1 - 18 of 18
|
Queue time:
Execution time:
|
0ms
549ms
|
| |
|
Related Terms:
|
paraneoplastic[18], syndromes[18], endocrine[12], of[7], and[5], in[5]
|
|
|
<<
<
1
>
>>
|
PMID
|
Text
|
4910210
|
Paraneoplastic endocrine syndromes. (1970 Jun)
paraneoplastic endocrine syndromes . description of a case of pulmonary hypertrophic osteoarthropathy and review of the literature
|
5837985
|
Paraneoplastic endocrine syndromes (1966 Jan)
paraneoplastic endocrine syndromes
|
4875065
|
Paraneoplastic endocrine syndromes (1968 Sep)
paraneoplastic endocrine syndromes
|
4360125
|
Paraneoplastic endocrine syndromes. (1974 Apr)
paraneoplastic endocrine syndromes . 2
|
6232062
|
Paraneoplastic endocrine syndromes (1984 Jun)
paraneoplastic endocrine syndromes
|
13947158
|
Paraneoplastic endocrine syndromes. (1963 Dec)
paraneoplastic endocrine syndromes . 1 . hypercorticism and visceral cancers .
|
13947159
|
Paraneoplastic endocrine syndromes. (1963 Dec)
paraneoplastic endocrine syndromes . II . hyperthyroidism and various endocrinopathies .
|
3013095
|
Paraneoplastic endocrine syndromes In some instances , tumors can produce signs and symptoms at a distance from the tumor or … (1986 Jul)
paraneoplastic endocrine syndromes In some instances , tumors can produce signs and symptoms at a distance from the tumor or its metastases . these are defined as paraneoplastic syndrome or humoral syndrome associated with neoplasms . paraneoplastic syndromes can arise from circulating substances secreted by tumors . The most well recognized and frequent concomitant of neoplasms is the production of hormones by nonendocrine tumors . these are usually called ectopic hormone producing tumors and bring about clinically endocrinologic manifestations secondary to hormone excess in patients with nonendocrine tumors . paraneoplastic endocrine syndromes frequently observed are cushing s syndrome due to ectopic production of ACTH , siadh due to ectopic production of ADH , hyper calcemia , hypoglycemia and so on . In order to establish a paraneoplastic etiology for alteration in hormone production , evidence that the hormone is produced by the tumor must be proved . paraneoplastic endocrine syndromes should be distinguished from hormone production by benign cells , hormone production by a malignancy of an endocrine organ or alterations in hormone production being due to infiltration into the endocrine organ by a primary tumor . The treatment of ectopic endocrine syndromes should be directed primarily at the tumor . because the course of this type of syndrome usually runs parallel to the course of the underlying tumor , the ectopically produced hormone can be a useful monitoring marker of the disease .
|
14139486
|
Paraneoplastic endocrine syndromes. (1964 Aug)
paraneoplastic endocrine syndromes .
|
6445411
|
Paraneoplastic endocrine syndromes in O. (1980 Jul)
paraneoplastic endocrine syndromes in O . R . L . ( ectopic secretion of polypeptide hormones )
|
5116727
|
Paraneoplastic endocrine syndromes. (1972 Jan)
paraneoplastic endocrine syndromes . apropos of 3 cases ( schwartz bartter , hypercorticism , hypercalcemia )
|
14739488
|
Paraneoplastic endocrine syndromes : a review. (2004 Jan)
paraneoplastic endocrine syndromes : a review . The paraneoplastic endocrine syndromes ( ectopic or inappropriate hormone production ) comprise a wide array of symptom complexes associated with malignant or less commonly benign neoplasms . Most of the syndromes are associated with the production of peptide hormones , which , in some instances , have autocrine stimulatory effects . hypercalcemia , the most common paraneoplastic endocrine syndrome , may be due to the systemic release of parathyroid hormone related protein ( pthrp ) , factors that may be produced locally ( cytokines ) , or by a combination of these mechanisms . A spectrum of other syndromes may be related to the production of specific hormones or growth factors , including insulin like growth factor and fibroblast growth factor 23 . molecular mechanisms responsible for the development of these syndromes are poorly understood . mutational events not only may initiate neoplastic transformation but may also lead to the activation ( re expression ) of genes responsible for hormone production . additionally , epigenetic events such as methylation may also be responsible for the development of these syndromes . It is likely that a multiplicity of genetic and epigenetic events may contribute to the development of paraneoplastic endocrine syndromes .
|
7704790
|
Paraneoplastic endocrine syndromes. (1995 May)
paraneoplastic endocrine syndromes .
|
2561752
|
Paraneoplastic endocrine syndromes (1990 Aug)
paraneoplastic endocrine syndromes
|
3686841
|
Proteohormones as markers of malignant tumors. (1988 Jan)
proteohormones as markers of malignant tumors . paraneoplastic endocrine syndromes
|
15718329
|
Uncommon presentations of some common malignancies : Case 1. (2005 Feb)
uncommon presentations of some common malignancies : Case 1 . sequential paraneoplastic endocrine syndromes in small cell lung cancer .
|
4409747
|
Hypertrophic osteoarthropathy in bronchopulmonary cancer and paraneoplastic endocrine syndromes (1974 Dec)
hypertrophic osteoarthropathy in bronchopulmonary cancer and paraneoplastic endocrine syndromes
|
4361017
|
Paraneoplastic endocrine syndromes. (1974 May)
paraneoplastic endocrine syndromes . 1
|
|
<<
<
1
>
>>
|
|
| You have no saved references. |
|
|